Michael Hadley: SCOT-HEART 2 Trail Could Transform How We Think About Identifying Those at Risk of Heart Attacks
Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn:
”The SCOT-HEART 2 trail could transform how we think about identifying those at risk of heart attacks.
This ongoing study is randomizing asymptomatic individuals ages 40-70 with 1 or more risk factors for heart disease to either Coronary CTA or standard care, with appropriate therapies, and following for a primary outcome of heart attack.
If the trial is positive, guidelines could recommend broader CT screening of asymptomatic adults, allowing us to detect and treat coronary disease earlier to prevent more heart attacks.
To prepare, we need to model out what a positive trial could mean for patient volumes and what it would take to meet that need.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies